Enteric Disease Testing Market, By Testing(Rapid, Traditional, PCR, Immunoassay, and Chromatography), By Disease, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Enteric Disease Testing Market size was valued at USD 3,987 Million in 2024, expanding to a CAGR of 3.5% from 2025 to 2032.
Enteric disease testing involves diagnosing infections that affect the gastrointestinal (GI) tract, often caused by bacteria, viruses, or parasites. These diseases are commonly transmitted through contaminated food, water, or contact with infected individuals or animals. Testing helps identify the specific pathogen responsible for symptoms such as diarrhea, vomiting, fever, and abdominal pain, enabling accurate diagnosis and treatment.
Enteric Disease Testing Market- Market Dynamics
Rising Incidence of Enteric Infections, Increased Focus on Food & Water Safety, and Technological Advancements to Drive Market Demand
The Enteric Disease Testing market is experiencing significant growth, driven by the rising global incidence of enteric diseases. These infections, caused by bacteria, viruses, and parasites, are frequently linked to contaminated food, water, and poor sanitation. According to the World Health Organization (WHO), diarrheal diseases remain the second leading cause of death in children under five, with many cases caused by enteric pathogens. The growing urban population, overcrowded living conditions, and inconsistent access to clean water have further fueled the spread of these diseases, creating a higher demand for diagnostic testing.
Additionally, governments, NGOs, and international organizations are intensifying efforts to promote food and water safety. Enteric pathogens such as Salmonella, E. coli, and Listeria are commonly responsible for foodborne illness outbreaks, increasing the pressure on food producers and water treatment facilities to implement regular and stringent testing protocols. The Food Safety Modernization Act (FSMA) in the U.S. has been a key regulatory measure, driving the need for enhanced pathogen detection methods across food and water supply chains. In 2023, the U.S. Food and Drug Administration (FDA) reported an increase in foodborne illness investigations, leading to a greater emphasis on advanced testing solutions. The shift from traditional stool cultures to advanced molecular diagnostics, including Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs), and Next-Generation Sequencing (NGS), has significantly improved detection sensitivity and speed. These technological advancements are helping accelerate market growth, enabling faster response times to outbreaks and improving overall public health safety.
Enteric Disease Testing Market- Segmentation Analysis:
The Global Enteric Disease Testing Market is segmented based on Testing, Disease, End Use, and Region.
The Enteric Disease Testing market is segmented into five categories based on testing methods: rapid, traditional, PCR, immunoassay, and chromatography. Among these, the rapid testing segment dominates the market due to the increasing demand for quick results and the convenience it offers. Rapid testing methods enable timely detection of enteric diseases, which is crucial for preventing outbreaks and ensuring public health safety. According to the U.S. Food and Drug Administration (FDA), the use of rapid diagnostic tests for infectious diseases, including enteric diseases, increased by 20% in 2023, driven by the need for faster, more efficient testing solutions.
The market is also divided into three categories based on disease type: bacterial, viral, and parasitic. The bacterial segment is expected to hold the largest share, largely due to the rising incidence of bacterial infections such as those caused by salmonella, shigella, E. coli, and campylobacter. These infections are significant contributors to the global burden of enteric diseases. According to the Centers for Disease Control and Prevention (CDC), bacterial infections like salmonella and E. coli led to over 1 million cases of foodborne illness in the U.S. alone in 2023, further emphasizing the growing need for accurate and rapid bacterial testing solutions.
Based on end use, the market is segmented into water and food, with the food segment holding the highest share. The increasing demand for convenience foods, including packed, processed, and frozen food products, is a major driver of growth in this segment. The growing concern about foodborne illnesses, coupled with stringent food safety regulations, has heightened the need for reliable enteric disease testing in the food industry. According to the U.S. Department of Agriculture (USDA), the U.S. food safety market is projected to grow by 6% annually through 2025, as demand for better quality control and disease prevention in food products increases.
Enteric Disease Testing Market- Geographical Insights
Geographically, the Enteric Disease Testing market is widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America, particularly the United States, holds a significant share of the global market due to well-established healthcare infrastructure, high awareness of enteric diseases, and advanced diagnostic technologies. The U.S. Centers for Disease Control and Prevention (CDC) reported that over 48 million Americans suffered from foodborne illnesses in 2023, highlighting the ongoing need for effective enteric disease testing. Asia Pacific, however, is expected to witness the fastest growth, driven by rising cases of waterborne and foodborne illnesses, particularly in regions with large populations and urbanization challenges. Poor sanitation and inadequate infrastructure in some areas have led to increased infections. The World Health Organization (WHO) reported that waterborne diseases account for over 80% of enteric disease outbreaks in developing countries, underscoring the demand for affordable and rapid testing solutions in rural areas. Additionally, investments in healthcare infrastructure and NGO-led initiatives aimed at improving disease management are further contributing to the growth of the market in this region. In Europe, there is a strong focus on public health surveillance and hospital infection control, with significant awareness of antimicrobial resistance (AMR). The European Centre for Disease Prevention and Control (ECDC) noted that AMR in enteric pathogens is a growing concern, with nearly 25% of infections caused by resistant bacteria in Europe in 2023, prompting a need for enhanced diagnostic and testing capabilities.
Enteric Disease Testing Market- Competitive Landscape:
The enteric disease diagnostics market is highly competitive, with companies focusing on technological advancements, rapid diagnostics, and multiplex testing panels. Multiplex panels are increasingly replacing traditional culture methods, allowing one test to detect multiple pathogens simultaneously. This innovation not only saves time but also improves diagnostic accuracy and yield. Companies are also heavily investing in regions like India, Brazil, and African countries to strengthen healthcare infrastructure. Furthermore, market players are actively engaging in new product launches and innovations aimed at enhancing the speed and efficiency of diagnostics.
Recent Developments:
- In April 2024, UNICEF, WHO, and other organizations deployed around 1.2 million cholera rapid diagnostic tests in Malawi to combat outbreaks.
- In 2024, Thermo Fisher Scientific made significant investments in AI-powered analytics for enhanced food pathogen surveillance, further advancing rapid diagnostics.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENTERIC DISEASE TESTING MARKET KEY PLAYERS
- BioMérieux
- BD (Becton, Dickinson and Company)
- Thermo Fisher Scientific
- Roche Diagnostics
- Abbott Laboratories
- QIAGEN
- DiaSorin
- Meridian Bioscience
- Hologic Inc.
- Cepheid
- Siemens Healthineers
- Danaher Corporation
- Agilent Technologies
- Merck KGaA
- Intertek
- Bio-Rad Laboratories
- Others
GLOBAL ENTERIC DISEASE TESTING MARKET, BY TESTING- MARKET ANALYSIS, 2019-2032
- Rapid
- Traditional
- PCR
- Immunoassay
- Chromatography
GLOBAL ENTERIC DISEASE TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019-2032
- Bacterial
- Viral
- Parasitic
GLOBAL ENTERIC DISEASE TESTING MARKET, BY END USE- MARKET ANALYSIS, 2019-2032
- Water
- Food
GLOBAL ENTERIC DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Enteric Disease Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Enteric Disease Testing Market Snippet by Testing
2.1.2. Enteric Disease Testing Market Snippet by Disease
2.1.3. Enteric Disease Testing Market Snippet by End Use
2.1.4. Enteric Disease Testing Market Snippet by Country
2.1.5. Enteric Disease Testing Market Snippet by Region
2.2. Competitive Insights
3. Enteric Disease Testing Key Market Trends
3.1. Enteric Disease Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Enteric Disease Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Enteric Disease Testing Market Opportunities
3.4. Enteric Disease Testing Market Future Trends
4. Enteric Disease Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Enteric Disease Testing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Enteric Disease Testing Market Landscape
6.1. Enteric Disease Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Enteric Disease Testing Market – By Testing
7.1. Overview
7.1.1. Segment Share Analysis, By Testing, 2024 & 2032 (%)
7.1.2. Rapid
7.1.3. Traditional
7.1.4. PCR
7.1.5. Immunoassay
7.1.6. Chromatography
8. Enteric Disease Testing Market – By Disease
8.1. Overview
8.1.1. Segment Share Analysis, By Disease, 2024 & 2032 (%)
8.1.2. Bacterial
8.1.3. Viral
8.1.4. Parasitic
9. Enteric Disease Testing Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
9.1.2. Water
9.1.3. Food
10. Enteric Disease Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Enteric Disease Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Enteric Disease Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Enteric Disease Testing Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Enteric Disease Testing Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Enteric Disease Testing Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Testing, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Enteric Disease Testing Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. BioMérieux
11.2.2. BD (Becton, Dickinson and Company)
11.2.3. Thermo Fisher Scientific
11.2.4. Roche Diagnostics
11.2.5. Abbott Laboratories
11.2.6. QIAGEN
11.2.7. DiaSorin
11.2.8. Meridian Bioscience
11.2.9. Hologic Inc.
11.2.10. Cepheid
11.2.11. Siemens Healthineers
11.2.12. Danaher Corporation
11.2.13. Agilent Technologies
11.2.14. Merck KGaA
11.2.15. Intertek
11.2.16. Bio-Rad Laboratories
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
